Porton Advanced │ Cell & Gene Therapy CDMO/CRO
Shelley HL Wu has extensive work experience in the biotech and medical industry. Shelley HL is currently the Head of Business Development/Commercial Team at Porton Advanced | Cell & Gene Therapy CDMO. Prior to this, they worked as the Senior Director of Business Development at PackGene Biotech, Inc. from 2022 to 2023. From 2017 to 2022, they served as the Senior Territory Manager at VectorBuilder. Before that, they worked as the Clinical/Research/Lab Manager at the Medical College of Georgia at Augusta University from 2013 to 2017. Shelley also held the role of Director of Sales at Jinfiniti Biosciences from 2010 to 2013 and worked as the Production Manager/Purchasing Manager at Teco Diagnostics from 2007 to 2010. Shelley HL'sresponsibilities included managing laboratory operations, overseeing manufacturing and production, and developing and executing purchasing strategies.
Shelley HL Wu earned a Master of Business Administration (M.B.A.) degree in Business Administration, Management and Operations from the University of California, Riverside from 2000 to 2002. Shelley HL also holds a Bachelor's degree in Biology/Biological Sciences, General from Tunghai University. Additionally, they have a Master of Science (MS) degree in Physiology, General from National Yang Ming University.
This person is not in any teams
This person is not in any offices
Porton Advanced │ Cell & Gene Therapy CDMO/CRO
Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP manufacturing, and testing services of AAV, Lentivirus, mRNA, and plasmid to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages. Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes. Our services include gene and cell engineering discovery research and technology licensing, process development and analytical development, testing, drug substances (DS) and drug products (DP), and cGMP manufacturing across plasmids, cell therapy, gene therapy, virotherapy, and mRNA-based therapeutic platforms. Contact us Business inquiry and collaboration Email: info@portonadvanced.com Visit our website to find out how Porton Advanced help sponsors to advance their programs.